Biocardia to host 2023 financial results and corporate update conference call on march 27, 2024

Sunnyvale, calif., march 20, 2024 (globe newswire) -- biocardia®, inc. [nasdaq:bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the year ended december 31, 2023 and provide a corporate update by conference call on wednesday, march 27, 2024 at 4:30 pm et.
BCDA Ratings Summary
BCDA Quant Ranking